CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
| Published in: | European Radiology Vol. 32; no. 3; pp. 1538 - 1548 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Mar2022
|
| Online Access: | View this record in EBSCOhost |